LEPU MED.T.B. SP.GDR O.N. (F:07Z0) — Market Cap & Net Worth
Market Cap & Net Worth: LEPU MED.T.B. SP.GDR O.N. (07Z0)
LEPU MED.T.B. SP.GDR O.N. (F:07Z0) has a market capitalization of $140.36K (€120.05K) as of June 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #31198 globally and #2794 in its home market, demonstrating a 1.54% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LEPU MED.T.B. SP.GDR O.N.'s stock price €13.20 by its total outstanding shares 9095 (9.10K). Review 07Z0 current and long-term liabilities to assess the company's total debt and financial obligations.
LEPU MED.T.B. SP.GDR O.N. Market Cap History: 2022 to 2026
LEPU MED.T.B. SP.GDR O.N.'s market capitalization history from 2022 to 2026. Data shows change from $131.27K to $140.36K (-0.58% CAGR).
LEPU MED.T.B. SP.GDR O.N. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LEPU MED.T.B. SP.GDR O.N.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
LEPU MED.T.B. SP.GDR O.N.'s market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
LEPU MED.T.B. SP.GDR O.N.'s market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $131.27K | $10.61 Billion | $2.20 Billion | 0.00x | 0.00x |
| 2023 | $149.93K | $7.98 Billion | $1.26 Billion | 0.00x | 0.00x |
| 2024 | $155.24K | $6.10 Billion | $246.94 Million | 0.00x | 0.00x |
| 2025 | $140.36K | $6.48 Billion | $962.01 Million | 0.00x | 0.00x |
Competitor Companies of 07Z0 by Market Capitalization
Companies near LEPU MED.T.B. SP.GDR O.N. in the global market cap rankings as of June 19, 2026.
Key companies related to LEPU MED.T.B. SP.GDR O.N. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
LEPU MED.T.B. SP.GDR O.N. Historical Marketcap From 2022 to 2026
Between 2022 and today, LEPU MED.T.B. SP.GDR O.N.'s market cap moved from $131.27K to $ 140.36K, with a yearly change of -0.58%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €140.36K | 0.00% |
| 2025 | €140.36K | -9.59% |
| 2024 | €155.24K | +3.55% |
| 2023 | €149.93K | +14.21% |
| 2022 | €131.27K | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of LEPU MED.T.B. SP.GDR O.N. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $140.36K USD |
| MoneyControl | $140.36K USD |
| MarketWatch | $140.36K USD |
| marketcap.company | $140.36K USD |
| Reuters | $140.36K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About LEPU MED.T.B. SP.GDR O.N.
Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro d… Read more